Researchers around the world are racing to get a vaccine against the coronavirus.
Nine candidates are already in the crucial phase.
All over the
world
,
research is being carried out
at
full
speed on a
vaccine
against the
coronavirus
.
Nine
candidates
from international
companies
and
research institutes
are currently in the crucial
test phase
.
However
, there are also
inconsistencies
with some potential
vaccines
against
Covid-19
.
Berlin - Both in terms of
containment of
the rampant coronavirus * and the development of a
vaccine
against
Covid-19
,
Germany
stands up
well in international comparison.
Despite the currently increasing number of cases, the currently falling R value gives hope *.
The
RKI also
expects that there will be several different vaccines * in Germany.
But not only in
Germany
is currently working flat out on a vaccine against the novel coronavirus *.
The
competition
from the international laboratories
not sleeping.
According to the WHO, a serum against
Covid-19 is being
sought
in 176 projects worldwide
.
Nine of these potential
vaccines
are currently
in the third and decisive test phase, in which the agent will be tested on tens of thousands of volunteers.
In some
countries
, parts of the
population are
even vaccinated,
according to their
governments
.
Coronavirus vaccine - these candidates are in the third phase of testing:
Company / research institute | country |
---|---|
University of Oxford / AstraZeneca | Great Britain / Sweden |
CanSino Biological Inc./Beijing Institute of Biotechnology | China |
Gamaleya Research Institute | Russia |
Janssen Pharmaceutical Companies | Belgium |
Sinovac | China |
Wuhan Institute of Biological Products / Sinopharm | China |
Beijing Institute of Biological Products / Sinopharm | China |
Moderna / NIAID | United States |
BioNTech / Pfizer | USA / Germany |
USA: positive developments - vaccine against coronavirus in "three or four weeks"
"We are about to have a vaccine," said
Donald Trump
on Tuesday evening on the US TV channel
ABC News
.
More precisely, the
US President
spoke
of "three or four weeks" in which one could have a
vaccine
against the
coronavirus
.
Health experts
and politicians in the
USA
criticize the fact that the elections on November 3rd of this year would put political pressure on the US drug
regulatory authority FDA
.
“A vaccination has to be safe, effective and trustworthy,” Caitlin Rivers wrote in advance on Twitter.
The epidemiologist at the University of Johns Hopkins in Baltimore said that
the
coronavirus
vaccine
must meet
all three criteria
: "It would be a tragedy if politicians, for political reasons, jeopardized the one thing that could allow us, ours return to normal life ”.
A vaccine must be safe, effective and trusted.
It's not a “pick 2” situation - we need all three.
It would be a tragedy if leaders jeopardized the thing that may allow us to safely return to our way of life for political expedience.
- Caitlin Rivers, PhD (@cmyeaton) August 22, 2020
The US pharmaceutical
company Pfizer
, which is working together with the Mainz-based company
Biontech
on a
serum
against the
coronavirus
, was meanwhile able to
celebrate its
first successes in the third
test phase
.
As the
ARD
reports, the
FDA has
now
promised
that the number of participants in the tests could be increased from 30,000 to 44,000 subjects.
If the results are positive, Pfizer and Biontech could
apply for
approval of the
vaccine
against the
coronavirus
as early as October
.
Russia: first approved vaccine against coronavirus - doubts about the veracity of the studies
+
Research is being carried out around the world for a vaccine against the coronavirus.
© Ted S. Warren / dpa
Russia
was the first country in the world that had approved a vaccine against the coronavirus in an urgent manner and is
already
vaccinating parts of the
population
- despite international concerns.
The third
phase of the study
on the
efficacy
and tolerability of
Sputnik-V
was not carried out prior to approval.
That caused a lot of criticism - experts even warned against the Russian vaccine against Covid-19.
As evidence of the effectiveness of
Sputnik-V
, the Russian
scientists
published
data on the
vaccine
against the
coronavirus
in the specialist journal
Lancet
at the beginning of September
.
However, some international
researchers
are
now questioning
the authenticity of these values and suspecting
Russia
of
manipulation
.
Upon closer inspection of the results, the experts
noticed
several
inconsistencies
, as reported by the
Frankfurter Rundschau
*.
China: First vaccinations against the coronavirus - open to the public in a few months
China
is represented with many candidates in the international race for a
vaccine
against the
coronavirus
, some of which are already
completing
the third
study test phase
.
In this context, there has already been international criticism due to allegedly outrageous methods.
According to the government,
soldiers are
already being
vaccinated
against
Covid-19
with a potential
serum
from the Institute of the People's Liberation Army
.
The development of a
vaccine
against the
coronavirus is
going "very smoothly", as an
epidemiologist from
the Center for
Disease Control
and Prevention
told
the Chinese TV broadcaster
CCTV
on Monday evening.
According to her, the serum could be made available to the public "around November or December".
However
, the epidemiologist did not disclose
which of the many Chinese
vaccine candidates
it is.
Great Britain / Sweden: Third test phase of vaccine against coronavirus continues
AstraZeneca
is also
a bearer of hope in the search for a
vaccine
against the
coronavirus
.
The Swedish-British pharmaceutical company recently suffered a major setback.
Last week, the
tests in
the third
phase of the study
had to be stopped - a test person is said to have contracted a rare neurological disease.
When the
test was stopped
, however, it was presumably a routine measure.
After a few days, the authorities confirmed that the disease was not due to the potential
vaccine
against the
coronavirus
.
The study by AstraZeneca is therefore now being continued.
(als) * Frankfurter Rundschau and Merkur.de is part of the nationwide Ippen digital editorial network.
List of rubric lists: © Ted S. Warren / dpa